Cargando…

Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway

OBJECTIVE: To investigate the changes in proinflammatory cytokines and chemokines, namely, C‐C motif ligand (CCL) 2 and CCL7, in postmenopausal osteoporosis (PMOP) and to develop a new drug, bindarit (Bnd), for PMOP in an ovariectomized (OVX) mouse model. METHODS: Bone marrow macrophages (BMMs) from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Shi‐guo, Hu, Hong‐ling, Wang, Xin‐jia, Yang, Jin‐cheng, Zhou, Rong‐ping, Bai, Xiao‐chun, Lai, Ping‐lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163972/ https://www.ncbi.nlm.nih.gov/pubmed/35470579 http://dx.doi.org/10.1111/os.13252

Ejemplares similares

The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
por: Ge, Shujun, et al.
Publicado: (2012)

Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment
por: Wolf, Stefan, et al.
Publicado: (2017)

Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties
por: Shen, Zongshan, et al.
Publicado: (2020)

The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
por: Lu, Tao, et al.
Publicado: (2016)

CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients
por: Farangis, Fatehi, et al.
Publicado: (2017)

Differential ligand-signaling network of CCL19/CCL21-CCR7 system
por: Raju, Rajesh, et al.
Publicado: (2015)

Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells
por: Grunz-Borgmann, Elizabeth, et al.
Publicado: (2015)

Involvement of Eotaxins (CCL11, CCL24, CCL26) in Pathogenesis of Osteopenia and Osteoporosis
por: AHMADI, Hadis, et al.
Publicado: (2020)

CCL3 in the bone marrow microenvironment causes bone loss and bone marrow adiposity in aged mice
por: Yu, Degang, et al.
Publicado: (2023)

Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions
por: Purvanov, Vladimir, et al.
Publicado: (2018)

CCL3 Promotes Proliferation of Colorectal Cancer Related with TRAF6/NF-κB Molecular Pathway
por: Ma, Xiaoqiang, et al.
Publicado: (2022)

4-Hexylresorcinol inhibits osteoclastogenesis by suppressing the NF-κB signaling pathway and reverses bone loss in ovariectomized mice
por: Yi, Wenkai, et al.
Publicado: (2021)

Pneumoperitoneum Modifies Serum and Tissue CCL2-CCL5 Expression in Mice
por: Papparella, Alfonso, et al.
Publicado: (2020)

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk
por: Kim, Joo Hyun, et al.
Publicado: (2016)

Ragweed-allergic subjects have decreased serum levels of chemokines CCL2, CCL3, CCL4 and CCL5 out of the pollen season
por: Kostova, Zhivka, et al.
Publicado: (2016)

Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8 chemokine expression
por: Hintzen, C, et al.
Publicado: (2009)

Prevention of Obesity Related Diseases through Laminarin-induced targeted delivery of Bindarit
por: Xu, Chunmei, et al.
Publicado: (2020)

Crucial biological functions of CCL7 in cancer
por: Liu, Yangyang, et al.
Publicado: (2018)

Higher Expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 Chemokines in the Skin Associated with Parasite Density in Canine Visceral Leishmaniasis
por: Menezes-Souza, Daniel, et al.
Publicado: (2012)

Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes
por: Polacchini, Alessio, et al.
Publicado: (2018)

Biochemical Analysis of Matrix Metalloproteinase Activation of Chemokines CCL15 and CCL23 and Increased Glycosaminoglycan Binding of CCL16
por: Starr, Amanda E., et al.
Publicado: (2012)

Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21
por: Unver, Nese
Publicado: (2021)

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes
por: Li, Rui, et al.
Publicado: (2014)

NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2016)

Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
por: Cho, Hyuck, et al.
Publicado: (2016)

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Gold nanoparticles enhances radiosensitivity in glioma cells by inhibiting TRAF6/NF-κB induced CCL2 expression
por: Wang, Hao, et al.
Publicado: (2023)

The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice
por: Grassia, Gianluca, et al.
Publicado: (2009)

Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
por: Guo, Wen, et al.
Publicado: (2021)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
por: Yang, Xue, et al.
Publicado: (2021)

CCR7‐CCL19/CCL21 Axis is Essential for Effective Arteriogenesis in a Murine Model of Hindlimb Ischemia
por: Nossent, A. Yaël, et al.
Publicado: (2017)

KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7
por: Kanyomse, Quist, et al.
Publicado: (2022)

Chemokines (CCL3, CCL4, and CCL5) Inhibit ATP-Induced Release of IL-1β by Monocytic Cells
por: Amati, Anca-Laura, et al.
Publicado: (2017)

Wheel-Running Exercise Protects Ovariectomized Mice from Bone Loss via IFN-γ-Mediated Suppression of the NF-κB and MAPK Pathways
por: Shen, Hao, et al.
Publicado: (2022)

CCR7 Sulfotyrosine Enhances CCL21 Binding
por: Phillips, Andrew J., et al.
Publicado: (2017)

Loss of RUNX3 expression promotes cancer‐associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non‐small cell lung cancer
por: Kim, Hyun‐Jeong, et al.
Publicado: (2015)

Scopolin Attenuates Osteoporotic Bone Loss in Ovariectomized Mice
por: Park, Eunkuk, et al.
Publicado: (2020)

Involvement of the Akt/NF-κB Pathways in the HTNV-Mediated Increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs
por: Yu, Haitao, et al.
Publicado: (2014)

Evolution of haplotypes at CCL3L1/CCL4L1
por: Janyakhantikul, Somwang, et al.
Publicado: (2010)

Differential Dermal Expression of CCL17 and CCL18 in Tuberculoid and Lepromatous Leprosy
por: Berrington, William R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i58sd2a24u6qt0d7ng3gjilp9f